Sign In
Buy IDXX
$560.73
+9.91 (+1.80%)
At Close: Jun 03, 2026
IART vs. IDXX: Which Stock Is the Better Value Option?
12:46pm, Friday, 13'th Oct 2023
Investors interested in Medical - Instruments stocks are likely familiar with Integra LifeSciences (IART) and Idexx Laboratories (IDXX). But which of these two stocks offers value investors a better b
3 Stocks Ready to Rocket on These Global Mega Trends
10:12am, Thursday, 28'th Sep 2023
Many investors are used to looking for sectors to make bets on. Technology.
Here's Why You Should Hold on to IDEXX (IDXX) Stock Right Now
02:17pm, Tuesday, 19'th Sep 2023
Investors are optimistic about IDEXX (IDXX) on solid premium instrument placements and upbeat guidance.
Which Is A Better Pick – Kimberly-Clark Stock Or IDEXX Laboratories?
08:00am, Friday, 15'th Sep 2023
Given its better prospects, we believe that IDEXX Laboratories stock (NASDAQ: IDXX) is a better pick over Kimberly-Clark stock (NYSE: KMB).
Here's Why You Should Invest in IDEXX (IDXX) Stock Right Now
12:34pm, Friday, 18'th Aug 2023
Investors continue to be optimistic about IDEXX (IDXX) due to the CAG business and the company's execution of its growth strategy.
3 Top Healthcare Stocks to Buy for August
09:15am, Saturday, 05'th Aug 2023
Humana delivered better-than-expected second-quarter earnings. Vertex Pharmaceuticals has three potential blockbuster therapies on the way.
Atlantic Equities Downgrades Idexx Laboratories
10:28pm, Wednesday, 02'nd Aug 2023
Fintel reports that on August 2, 2023, Atlantic Equities downgraded their outlook for Idexx Laboratories (NASDAQ:IDXX) from Overweight to Neutral.
IDEXX Laboratories, Inc. (IDXX) Q2 2023 Earnings Call Transcript
01:40pm, Tuesday, 01'st Aug 2023
IDEXX Laboratories, Inc. (NASDAQ:IDXX ) Q2 2023 Earnings Conference Call August 1, 2023 8:30 AM ET Company Participants Jay Mazelsky - President and Chief Executive Officer Brian McKeon - Chief Financ
IDEXX (IDXX) Q2 Earnings and Revenues Beat Estimates, View Up
12:40pm, Tuesday, 01'st Aug 2023
IDEXX (IDXX) delivers better-than-expected earnings and revenues in the second quarter of 2023, backed by CAG Diagnostics' recurring revenue growth.
Idexx (IDXX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
12:40pm, Tuesday, 01'st Aug 2023
The headline numbers for Idexx (IDXX) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates a
Idexx Laboratories (IDXX) Q2 Earnings and Revenues Beat Estimates
08:55am, Tuesday, 01'st Aug 2023
Idexx Laboratories (IDXX) came out with quarterly earnings of $2.67 per share, beating the Zacks Consensus Estimate of $2.43 per share. This compares to earnings of $1.56 per share a year ago.
IDEXX Laboratories (IDXX) to Post Q2 Earnings: What's in Store?
08:27am, Friday, 21'st Jul 2023
IDEXX Laboratories' (IDXX) second-quarter 2023 results are expected to reflect an impressive performance in the CAG segment.
Idexx Laboratories (IDXX) is a Top-Ranked Momentum Stock: Should You Buy?
11:09am, Friday, 14'th Jul 2023
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
IDEXX: One Of The Best Compounders On The Market
06:01pm, Thursday, 29'th Jun 2023
IDEXX Laboratories, a healthcare supplier specializing in veterinary health diagnostics and research, is a potential high-performing compounder due to its wide-moat business model, anti-cyclical custo
IDEXX (IDXX) Stock Up 18.4% YTD: Will the Rally Continue?
11:43am, Monday, 19'th Jun 2023
The continued solid demand for veterinary services and benefits from strong execution poise IDEXX (IDXX) well for future growth.
